Patient preferences were not discussed. Background papers providing critical appraisal of the evidence and tentative recommendations prepared by the chapter author were pre-circulated to the members. Consensus was reached on final recommendations. Benefits, Harms, and Costs HI is labour-intensive and has a high rate of false positive and negative results. No population studies evaluated effectiveness of screening and rubella vaccination in reducing congenital rubella syndrome.
Vaccination is long lasting and efficacious.
Rubella vaccine is contraindicated during pregnancy because of the theoritical possibility of teratogenicity. Adverse effects of live attenuated vaccine are mild and commonly include joint symptoms in adults. Citations in support of individual recommendations are identified in the guideline text. The decision of which strategy to use should be tailored to the individual clinician's practice population, depending on the availability of vaccination records, the rate of immunity, the cost of serologic testing and of follow-up vaccination for susceptible people. This report was externally peer reviewed.